Stephen F. Kemp
Section of Endocrinology
University of Arkansas for Medical Sciences at Arkansas Children's Hospital
Little Rock
AR 72202
USA
Name/email consistency: high
- Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options. Kemp, S.F. BioDrugs (2009)
- Mecasermin rinfabate. Kemp, S.F. Drugs. Today (2007)
- Investigational agents for the treatment of growth hormone-insensitivity syndrome. Kemp, S.F., Thrailkill, K.M. Expert. Opin. Investig. Drugs (2006)
- Efficacy and safety of mecasermin rinfabate. Kemp, S.F., Fowlkes, J.L., Thrailkill, K.M. Expert. Opin. Biol. Ther (2006)
- SomatoKine: is there a use in treating growth disorders?. Kemp, S.F., Thrailkill, K.M. Curr. Opin. Investig. Drugs (2005)
- Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. Kemp, S.F., Kuntze, J., Attie, K.M., Maneatis, T., Butler, S., Frane, J., Lippe, B. J. Clin. Endocrinol. Metab. (2005)
- Growth hormone treatment of idiopathic short stature: history and demographic data from the NCGS. Kemp, S.F. Growth Horm. IGF Res. (2005)
- Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children. Kemp, S.F., Fielder, P.J., Attie, K.M., Blethen, S.L., Reiter, E.O., Ford, K.M., Marian, M., Dao, L.N., Lee, H.J., Saenger, P. J. Clin. Endocrinol. Metab. (2004)
- Use of magnetic resonance imaging in short stature: data from National Cooperative Growth Study (NCGS) Substudy 8. Kemp, S.F., Alter, C.A., Dana, K., Baptista, J., Blethen, S.L. J. Pediatr. Endocrinol. Metab. (2002)